SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,026.04 -223.35
( -0.30%)

Global Indices

Nasdaq

52,891.50 14.41
(0.03%)

Dow Jones

7,684.38 -93.79
(-1.21%)

Hang Seng

63,134.14 -1,487.10
(-2.30%)

Nikkei 225

10,723.99 -28.89
(-0.27%)

Forex

USD-INR

94.51 -0.31
(-0.33%)

EUR-INR

106.10 -0.35
(-0.33%)

GBP-INR

126.51 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Symbiotec Pharmalab Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544889

INE899I01028

195.2322192

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYMBIOTEC

49.38

7698.2

EPS(TTM)

Face Value()

Div & Yield %

24.26

Back

bajaj finance ltd

Bajaj Finance consolidated net profit rises 27.37% in the June 2026 quarter

Aug 21,2026

Net profit of Bajaj Finance rose 27.37% to Rs 5985.75 crore in the quarter ended June 2026 as against Rs 4699.61 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 23023.46 crore in the quarter ended June 2026 as against Rs 19255.19 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	23023.46	19255.19	20
OPM %	71.11	70.28	-
PBDT	8436.55	6619.07	27
PBT	8149.00	6367.58	28
NP	5985.75	4699.61	27

73,026.04 -223.35 ( -0.30%)

52,891.50 14.41 (0.03%)

7,684.38 -93.79 (-1.21%)

63,134.14 -1,487.10 (-2.30%)

10,723.99 -28.89 (-0.27%)

94.51 -0.31 (-0.33%)

106.10 -0.35 (-0.33%)

126.51 -0.13 (-0.10%)

0.60 0.00 (-0.28%)